Seminole Management’s GSK GSK Stock Holding History

Seminole Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-101,044	Closed	-$5.45M	–	48
2016 Q3	$5.45M	Buy	101,044 +89,444	+771%	+$4.9M	0.93%	27
2016 Q2	$628K	Buy	+11,600	New	+$611K	0.06%	46
2015 Q2	–	Sell	-846,981	Closed	-$48.9M	–	71
2015 Q1	$48.9M	Buy	+846,981	New	+$48.6M	2.19%	14
2014 Q2	–	Sell	-216,960	Closed	-$14.5M	–	72
2014 Q1	$14.5M	Hold	216,960	–	–	0.69%	43
2013 Q4	$14.5M	Hold	216,960	–	–	0.72%	41
2013 Q3	$13.6M	Hold	216,960	–	–	0.86%	35
2013 Q2	$13.6M	Buy	+216,960	New	+$13.8M	0.77%	38

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Seminole Management's GSK Position: Q4 2016 in Review

Seminole Management sold out of GSK (GSK) in Q4 2016, closing a stake of 101,044 shares — an estimated $5.45M sold.

Seminole Management first reported a position in GSK in Q2 2013 and held it in 7 quarters. The position peaked at $48.9M in Q1 2015. 762 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

Seminole Management reported no remaining GSK position as of Q4 2016 after selling out during the quarter.
Seminole Management sold 101,044 GSK shares in Q4 2016, an estimated $5.45M.
Seminole Management first reported a position in GSK in Q2 2013 and held it in 7 quarters.
Seminole Management's GSK position peaked at $48.9M in Q1 2015.
762 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on Seminole Management's 13F filing for Q4 2016, filed 20 Jan 2017.